Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial

PURPOSE: The overexpression of cyclooxygenase 2 (COX-2) gene, also known as prostaglandin-endoperoxide synthase 2 (PTGS2), occurs in breast cancer, but whether it affects response to anticox drugs remains unclear. We investigated the relationships between PTGS2 expression, celecoxib use during neoad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Hamy, Anne-Sophie, Tury, Sandrine, Wang, Xiaofei, Gao, Junheng, Pierga, Jean-Yves, Giacchetti, Sylvie, Brain, Etienne, Pistilli, Barbara, Marty, Michel, Espié, Marc, Benchimol, Gabriel, Laas, Enora, Laé, Marick, Asselain, Bernard, Aouchiche, Brice, Edelman, Martin, Reyal, Fabien
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804843/
https://ncbi.nlm.nih.gov/pubmed/30702971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00636
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados